Lumateperone 42 mg in an Open-Label Switch Study in Patients with Stable Schizophrenia: Results by Previous Antipsychotic

被引：0
|
作者：
Cutler, Andrew J. [1 ]
Edwards, John B. [2 ]
Durgam, Suresh [2 ]
Mo, Yifan [2 ]
Acosta, Jazmin [2 ]
Davis, Robert E. [2 ]
机构：
[1] SUNY Upstate Med Univ, Dept Psychiat, Lakewood Ranch, FL USA
[2] Intra Cellular Therapies Inc, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001645
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：235 / 236
页数：2
相关论文
共 50 条
  • [41] Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
    de Oliveira, Irismar Reis
    Elkis, Helio
    Gattaz, Wagner Farid
    Chaves, Ana Cristina
    de Sena, Eduardo Ponde
    de Matos e Souza, Fabio Gomes
    Campos, Joao Alberto
    Bueno, Joao Romildo
    Costa e Silva, Jorge Alberto
    Louza, Mario Rodrigues
    de Abreu, Paulo Belmonte
    CNS SPECTRUMS, 2009, 14 (02) : 93 - 102
  • [42] An open-label extension study of lurasidone in patients with schizophrenia previously randomized to lurasidone or risperidone
    Mattingly, G.
    Tocco, M.
    Cucchiaro, J.
    Xu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S559 - S559
  • [43] Quetiapine ('Seroquel') and olanzapine for acute treatment of patients with schizophrenia: An open-label, comparative study
    Reznik, I
    Slavkin, L
    Shabash, E
    Shaked, G
    Kertzman, S
    Spivak, B
    Weizman, A
    Kotler, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S244 - S244
  • [44] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [45] Aripiprazole versus olanzapine in patients with acutely relapsing or chronic, stable schizophrenia: A 52-week open-label extension study
    Sanchez, R
    Kostic, D
    Stock, E
    Torbeyns, A
    Kerselaers, W
    Nyilas, M
    McQuade, R
    Carson, W
    Marcus, R
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 65 - 65
  • [46] Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study
    Takeuchi, Hiroyoshi
    Suzuki, Takefumi
    Remington, Gary
    Bies, Robert R.
    Abe, Takayuki
    Graff-Guerrero, Ariel
    Watanabe, Koichiro
    Mimura, Masaru
    Uchida, Hiroyuki
    SCHIZOPHRENIA BULLETIN, 2013, 39 (05) : 993 - 998
  • [47] Olanzapine optimal dose: Results of an open-label multicenter study in schizophrenic patients
    Ishigooka, J
    Murasaki, M
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2000, 54 (04) : 467 - 478
  • [48] Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study
    Pae, Chi-Un
    Serretti, Alessandro
    Chiesa, Alberto
    Mandelli, Laura
    Lee, Changuk
    Lee, Chul
    Kim, Jungjin
    De Ronchi, Diana
    Paik, In-Ho
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 562 - 570
  • [49] Aripiprazole in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: An Open-Label Study of 15 Patients
    Glick, Ira D.
    Poyurovsky, Michael
    Ivanova, Oxana
    Koran, Lorrin M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (12) : 1856 - 1859
  • [50] Long-term lumateperone treatment in bipolar disorder: Six-month open-label extension study
    Tohen, Mauricio
    D'Souza, Ian
    Kozauer, Susan G.
    Chen, Changzheng
    Durgam, Suresh
    BIPOLAR DISORDERS, 2023, 25 : 96 - 96
12345